Association between methylenetetrahydrofolate reductase polymorphisms, alcohol intake and oropharyngolaryngeal carcinoma in northern Italy

Journal of Laryngology and Otology

Volumn 119, Issue 5, 2005, Pages 371-376

  Capaccio, Pasquale ^a   Ottaviani, Francesco ^a   Cuccarini, Valeria ^a   Cenzuales, Salvatore ^a   Cesana, Bruno Mario ^b   Pignataro, Lorenzo ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Alcohol Consumption; Carcinoma; Folate; Head and Neck Neoplasms; Mutation

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); FOLIC ACID;

ALCOHOL CONSUMPTION; ARTICLE; CANCER EPIDEMIOLOGY; CANCER LOCALIZATION; CANCER RISK; CANCER SUSCEPTIBILITY; DNA ISOLATION; DNA POLYMORPHISM; ENZYME ACTIVITY; GENE FREQUENCY; GENE MUTATION; GENETIC SUSCEPTIBILITY; GENOTYPE; GLOTTIS; HETEROZYGOSITY; HOMOZYGOSITY; ITALY; LARYNX CARCINOMA; LEUKOCYTE; OROPHARYNX CARCINOMA;

ALCOHOL DRINKING; FEMALE; GENOTYPE; HUMANS; ITALY; LARYNGEAL NEOPLASMS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; MOUTH NEOPLASMS; MUTATION; PHARYNGEAL NEOPLASMS; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 20044393717     PISSN: 00222151     EISSN: None     Source Type: Journal    
DOI: 10.1258/0022215053945831     Document Type: Article

References (50)

1. Scott J, Weir D. Folic acid, homocysteine and one-carbon metabolism: a review of the essential biochemistry. J Cardiovasc Risk 1998;5:223-7
2. Ryan BM, Weir DG. Relevance of folate metabolism in the pathogenesis of colorectal cancer. J Lab Clin Med 2001;138:164-76
3. Choi SW, Mason JB. Folate and carcinogenesis: an integrated scheme. J Nutr 2000;130:129-32
4. Thurmon TF. Folic acid: miscarriages, anomalies, thromboses, cancers. J La State Med Soc 2001;123:98-103
5. Eads CA, Lord RV, Wickramasinghe K, Long TI, Kurumboor SK, Bernstein L, et al. Epigenetic patterns in the progression of esophageal adenocarcinoma. Cancer Res 2001;61:3410-18
6. Potter JD. Colorectal cancer: molecules and populations. J Natl Canc Inst 1999;91:916-32
7. Stern LL, Mason JB, Selhub J, Choi SW. Genomic DNA hypomethylation, a characteristic of most cancers, is present in peripheral leukocytes of individuals who are homozygous for the C677T polymorphism in the methylenetetrahydrofolate reductase gene. Cancer Epidemiol Biomarkers Prev 2000;9:849-53
8. Sacchi E, Tagliabue L, Duca F, Mannucci PM. High frequency of the C&//T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene in northern Italy. Thromb Haemost 1997;78:963-4
9. Abbate R, Sardi I, Pepe G, Marcucci R, Brunelli T, Prisco D, et al. The high prevalence of thermolabile 5-10 methylenetetrahydrofolate reductase (MTHFR) in Italians is not associated with an increased risk for coronary artery disease (CAD). Thromb Haemost 1998;79:727-30
10. De Marco P, Calevo MG, Moroni A, Arata L, Merello E, Finnell RH, et al. Study of MTHFR and MS polymorphisms as risk factors for NTD in the Italian population. J Hum Genet 2002;47:319-24
11. MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 1991;338:131-7
12. Green R, Jacobsen D. Clinical implications of hyperhomocysteinaemia. In: Bailey L, ed. Folate in Health and Disease. New York: Marcel Dekker, 1995;75-122
13. Selhub J, D'Angelo A. Relationship between homocysteine and thrombotic disease. Am J Med Sci 1998;316:129-41
14. Scott J, Weir D. Homocysteine and cardiovascular diseases. Q J Med 1996;89:561-3
15. Mills JL, McPartlin JM, Kirke PN, Lee YJ, Conley MR, Weir DG, et al. Homocysteine metabolism in pregnancies complicated by neural tube defects. Lancet 1995;345:149-51
16. Wouters MGAJ, Boers GHJ, Blom HJ, Trijbels JMF, Thomas CMG, Borm GF, et al. Hyperhomocysteinaemia: a risk factor in women with unexplained recurrent early pregnancy loss. Fertil Steril 1993;60:820-5
17. Lucock M. Folic acid: nutritional biochemistry, molecular biology, and role in disease processes. Mol Genet Metab 2000;71:121-38
18. Frosst P, Blom HJ, Milos R, Gryette P, Shepard CA, Mattews RG, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995;10:111-3
19. Weisberg I, Tran P, Christensen B, Sibani S, Rozen R. A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab 1998;64:169-72
20. Song C, Xing D, Tan W, Wei Q, Lin D. Methylenetetrahydrofolate reductase polymorphisms increase risk of esophageal squamous cell carcinoma in a Chinese population. Cancer Res 2001;61:3272-5
21. Shen H, Xu Y, Qian Y, Yu R, Qin Y, Wang X, et al. Polymorphisms of 5,10-methylenetetrahydrofolate reductase and risk of gastric cancer in a Chinese population: a case-control study. Int J Cancer 2001;95:332-6
22. Gao G, Wu J, Liu Y, Zang Y, Li S, Su P, et al. Polymorphisms of methylenetetrahydrofolate reductase C677T and the risk of stomach cancer. Zhonghua Liu Xing Bing Xue Za Zhi 2002;23:289-92
23. Houlston RS, Tomlinson IPM. Polymorphisms and colorectal tumor risk. Gastroenterology 2001;121:282-301
24. Ryan BM, Weir DG. Relevance of folate metabolism in the pathogenesis of colorectal cancer. J Lab Clin Med 2001;138:164-76
25. Park KS, Mok JW, Kim JC. The 677C>T mutation in 5,10- methylenetetrahydrofolate reductase and colorectal cancer risk. Genet Test 1999;3:233-6
26. Keku T, Millikan R, Worley K, Winkel S, Eaton A, Biscocho L, et al. 5,10-Methylenetetrahydrofolate reductase codon 677 and 1298 polymorphisms and colon cancer in African Americans and whites. Cancer Epidemiol Biomarkers Prev 2002;11:1611-21
27. Sellers TA, Kushi LH, Cerhan JR, Vierkant RA, Gapstur SM, Vachon CM, et al. Dietary folate intake, alcohol, and risk of breast cancer in a prospective study of postmenopausal women. Epidemiology 2001,12:420-8
28. Esteller M, Garcia A, Martinez-Palones JM, Xercavins J, Reventos J. Germ line polymorphisms in cytochrome-P450 1A1 (C4887 CYP1A1) and methylenetetrahydrofolate reductase (MTHFR) genes and endometrial cancer susceptibility. Carcinogenesis 1997;18:2307-311
29. Matsuo K, Suzuki R, Hamajima N, Ogura M, Kagami Y, Taji H, et al. Association between polymorphisms of folate and methionine-metabolizing enzymes and susceptibility to malignant lymphoma. Blood 2001;97:3205-9
30. Franceschi S, Talamini R, Barra S, Baron AF, Negri E, Bidoli E, Serraino D, La Vecchia C. Smoking and drinking in relation to cancers of the oral cavity, pharynx, larynx and esophagus in Northern Italy. Cancer Res 1990;50:6502-7
31. Stern LL, Mason JB, Selhub J, Choi SW. Genomic DNA hypomethylation, a characteristic of most cancers, is present in peripheral leukocytes of individuals who are homozygous for the C677T polymorphism in the methylenetetrahydrofolate reductase gene. Cancer Epidemiol Biomarkers Prev 2000;9:849-53
32. Soler M, Bosetti C, Franceschi S, Negri E, Zambon P, Talamini R, et al. Fiber intake and the risk of oral, pharyngeal and esophageal cancer. Int J Cancer 2001;91:283-7
33. Kasum CM, Jacobs DRJ, Nicodemus K, Folsom AR. Dietary risk factors for upper aerodigestive tract cancers. Int J Cancer 2002;99:267-72
34. Franceschi S, Favero A, Conti E, Talamini R, Volpe R, Negri E, et al. Food groups, oils and butter, and cancer of the oral cavity and pharynx. Br J Cancer 1999;80:614-20
35. Franceschi S, Bidoli E, Baron AE, Barra S, Talamini R, Serraino D, et al. Nutrition and cancer of the oral cavity and pharynx in North-East Italy. Int J Cancer 1991;47:20-5
36. Franceschi S, Levi F, La Vecchia C, Conti E, Dal Maso L, Barzan L, et al. Comparison of the effect of smoking and alcohol drinking between oral and pharyngeal cancer. Int J Cancer 1999;83:1-4
37. Balaram P, Sridhar H, Rajkumar T, Vaccarella S, Herrero R, Nandakumar A, et al. Oral cancer in southern India: the influence of smoking, drinking, paan-chewing and oral hygiene. Int J Cancer 2002;98:440-5
38. Franceschi S, Talamini R, Barra S, Baron AE, Negri AE, Bidoli E, et al. Smoking and drinking in relation to cancers of the oral cavity, pharynx, larynx and esophagus in northern Italy. Cancer Res 1990;50:6502-7
39. Barra S, Franceschi S, Negri E, Talamini R, La Vecchia C. Type of alcoholic beverage and cancer of the oral cavity, pharynx and oesophagus in an Italian area with high wine consumption. Int J Cancer 1990;46:1017-20
40. Talamini R, Franceschi S, Barra S, La Vecchia C. The role of alcohol in oral and pharyngeal cancer in non-smokers, and of tobacco in non-drinkers. Int J Cancer 1990;46:391-3
41. Bosetti C, Gallus S, Franceschi S, Levi F, Bertuzzi M, Negri E, et al. Cancer of the larynx in non-smoking alcohol drinkers and in non-drinking tobacco smokers. Br J Cancer 2002;87:516-8
42. Mashberg A, Boffetta P, Winkelman R, Garfinkel L. Tobacco smoking, alcohol drinking, and cancer of the oral cavity and oropharynx among US veterans. Cancer 1993;77:1369-75
43. Boffetta P, Mashberg A, Winkelmann R, Garfinkel L. Carcinogenic effect of tobacco smoking and alcohol drinking on anatomic sites of the oral cavity and oropharynx. Int J Cancer 1992;52:530-3
44. Zheng TZ, Boyle P, Hu HF, Jiang PJ, Ma DQ, Niu SR, et al. Tobacco smoking, alcohol consumption, and risk of oral cancer: a case-control study in Beijing, People's Republic of China. Cancer Causes Control 1990;1:173-9
45. Baron AE, Franceschi S, Barra S, Talamini R, La Vecchia C. A comparison of the joint effects of alcohol and smoking on the risk of cancer across sites in the upper aerodigestive tract. Cancer Epidemiol Biomarkers Prev 1993;2:519-23
46. Slattery ML, Potter JD, Samowitz W, Shaffer D, Leppert M. Methylenetetrahydrofolate reductase, diet, and risk of colon cancer. Cancer Epidemiol Biom Prev 1999;8:513-18
47. Eichholzer M, Luthy J, Moser U, Fowler B. Folate and the risk of colorectal, breast and cervix cancer: the epidemiological evidence. Swiss Med Wkly 2001;131:539-49
48. Weinstein SJ, Gridley G, Harty LC, Diehl SR, Brown LM, Winn DM, et al. Folate intake, serum homocysteine and methylenetetrahydrofolate reductase (MTHFR) C677T genotype are not associated with oral cancer risk in Puerto Rico. J Nutr 2002;132:762-7
49. Isotalo PA, Wells GA, Donnelly JG Neonatal and fetal methylenetetrahydrofolate reductase genetic polymorphisms: an examination of C677T and A1298C mutations. Am J Hum Genet 2000;67:986-90
50. La Vecchia C, Negri E, Franceschi S, Decarli A, Boyle P. Cancer mortality in Europe: effects of age, cohort of birth and period of death. Eur J Cancer 1998;34:118-41